I am going to take a deep dive into Biomics Biopharma Limited’s (ASX:BBM) most recent ownership structure, not a frequent subject of discussion among individual investors. Ownership structure has been ...
Farmington, CONN. – General Biomics, Inc. and The Jackson Laboratory (JAX) announced an expansive and exclusive intellectual property licensing agreement across six areas of human health. The ...
Maverix Analytic Platform integrates with Elsevier Pathway Studio for seamless NGS analysis workflow to assist critical decision making SAN FRANCISCO, CALIFORNIA February 16, 2015: Maverix Biomics Inc ...
SAN MATEO, CALIFORNIA – Maverix Biomics, Inc., a leading genomic analysis software company, today announced the appointment of J. Thomas Kent as Vice President of Research & Development. Mr. Kent has ...
SAN MATEO — Maverix Biomics, a startup co-founded by UC Santa Cruz professor of biomolecular engineering Todd Lowe, announced Tuesday it has closed a $6 million funding round, its first. Asset ...
The BIOMICs Group, based at the Lucio Lascaray building in the Álava/Araba campus of the University of the Basque Country (UPV/EHU), is specially known for overseeing the SGIker DNA Bank, not only ...
HAYWARD, Calif.--(BUSINESS WIRE)--Applied Biomics, Inc., a leading Proteomics service provider, launches a new product line offering Anti-HCP Antibodies with well over 95% coverage. Currently, the ...
Drug has broad applications for bone health - osteoporosis, fracture healing, osteoarthritis and other endocrinological conditions. CSIR-Central Drug Research Institute (CDRI), Lucknow, one of the ...
HAYWARD, Calif.--(BUSINESS WIRE)--Applied Biomics, Inc., a leading Proteomics service provider, adds a HCP profiling analysis using their well established high resolution, large format 2-Dimensional ...
Applied Biomics announced expanding its services to full-line Proteomics services. The newly expanded service line covers from sample preparation to generating high quality data ready for publication.
BEDFORD, MA, UNITED STATES, April 30, 2025 / EINPresswire.com / -- Aveta Biomics, a clinical-stage biotechnology company developing first-in-class drugs that reprogram the immune system to fight ...
Maverix Biomics Inc., announced at the 23rd International Molecular Medicine Tri-Conference (Tricon) in San Francisco CA that the company has signed a strategic cooperation agreement with Elsevier, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results